PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
21-Oct-2025 Broughton upholds compliance standards with UKAS and MHRA Broughton
21-Oct-2025 Study Shows CLn BodyWash Helps People With Hidradenitis Suppurativa (HS) Improve Comfort and Confidence ACCESS Newswire
21-Oct-2025 Exeliom Biosciences secures €2.85M extension to Series A funding, bringing total round to nearly €12M Andrew Lloyd Associates
21-Oct-2025 Adaptyx Raises $14M in Seed Financing to Launch Wearable Platform for Continuous Multi-Analyte Molecular Monitoring Adaptyx
21-Oct-2025 NDT Pharmaceuticals Showcases Strategic Value of Good Salt(TM) Life Acquisition with Expanded Relationship with Norwegian Cruise Line ACCESS Newswire
21-Oct-2025 Tenon Medical(R) Announces FDA 510(k) Clearance for SImmetry(R)+ SI Joint Fusion System ACCESS Newswire
21-Oct-2025 NHS Confederation responds to NHS AI trial results delivering cost savings NHS Confederation
21-Oct-2025 Global Fund welcomes renewed commitment from GSK and ViiV Healthcare to expand community-led health solutions with £6 million joint pledge ahead of 8th Replenishment Global Fund
21-Oct-2025 DKSH Cambodia Promotes Equity in Women’s Health Through Free Breast Cancer Screenings on “Patient Purpose Day 2025” DKSH Cambodia
21-Oct-2025 Syncona Limited (“Syncona” or the “Company”) Strategy update Syncona
21-Oct-2025 Kelso Pharma prepares for further European growth as Velit Biopharma rebrands as Kelso Pharma Italy Kelso Pharma Italy
21-Oct-2025 Kelso Pharma prepares for further European growth as Velit Biopharma rebrands as Kelso Pharma Italy Kelso Pharma
21-Oct-2025 GSK’s Shingrix new prefilled syringe presentation receives positive CHMP opinion GSK
21-Oct-2025 Astraveus further strengthens world class leadership team to advance development of Lakhesys Benchtop Cell Factory™ Astraveus
21-Oct-2025 ‘Smart jab’ shows promise in treating advanced head and neck cancer The Institute of Cancer Research
21-Oct-2025 4.0% Organic Revenue Growth in 9M 2025; Eurofins on Track for Solid Full Year Growth and Margin Expansion Businesswire
21-Oct-2025 NuCana Presents Encouraging Data on NUC-7738 in Combination with PD-1 Inhibitors using Primary Patient-Derived Organoids and Autologous Tumor-Infiltrating Lymphocytes at the ESMO Congress 2025 NuCana
21-Oct-2025 Global study challenges ‘cancer epidemic’ in young adults – with one exception The Institute of Cancer Research
21-Oct-2025 Sanofi’s high-dose influenza vaccine demonstrates superior protection for older adults against hospitalization vs standard-dose Sanofi
21-Oct-2025 ESMO: AlphaMedixTM phase 2 data support first-in-class potential of new targeted alpha therapy in gastroenteropancreatic neuroendocrine tumors Sanofi